Goncalves Joana
Reporting owner on Forms 3, 4 and 5, CIK 1756991.
Goncalves Joana reported on 1 issuer in 2 filings, the latest a Form 4 filed 2026-11-16.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| ORKA · Oruka Therapeutics, Inc.CIK 907654 | officer (Chief Medical Officer) | 2 | 2026-11-16 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| ORKA · Oruka Therapeutics, Inc.Common Stock | 2026-11-16 | M exercised | +3,500 | $6.84 | 35,271 | Form 4 |
| ORKA · Oruka Therapeutics, Inc.Common Stock | 2026-11-16 | M exercised | +3,500 | $7.8 | 38,771 | Form 4 |
| ORKA · Oruka Therapeutics, Inc.Common Stock | 2026-11-16 | S sold | -2,600 | $99.515 | 36,171 | Form 4 |
| ORKA · Oruka Therapeutics, Inc.Common Stock | 2026-11-16 | S sold | -1,500 | $100.4792 | 34,671 | Form 4 |
| ORKA · Oruka Therapeutics, Inc.Common Stock | 2026-11-16 | S sold | -1,900 | $101.5268 | 32,771 | Form 4 |
| ORKA · Oruka Therapeutics, Inc.Common Stock | 2026-11-16 | S sold | -300 | $102.47 | 32,471 | Form 4 |
| ORKA · Oruka Therapeutics, Inc.Common Stock | 2026-11-16 | S sold | -200 | $103.36 | 32,271 | Form 4 |
| ORKA · Oruka Therapeutics, Inc.Common Stock | 2026-11-16 | S sold | -500 | $105.856 | 31,771 | Form 4 |
| ORKA · Oruka Therapeutics, Inc.Employee Stock Option (right to buy), derivative | 2026-11-16 | M exercised | -3,500 | $0 | 186,563 | Form 4 |
| ORKA · Oruka Therapeutics, Inc.Employee Warrant (right to buy), derivative | 2026-11-16 | M exercised | -3,500 | $0 | 157,992 | Form 4 |
| ORKA · Oruka Therapeutics, Inc.Common Stock | 2026-10-15 | M exercised | +3,500 | $6.84 | 35,271 | Form 4 |
| ORKA · Oruka Therapeutics, Inc.Common Stock | 2026-10-15 | M exercised | +3,500 | $7.8 | 38,771 | Form 4 |
| ORKA · Oruka Therapeutics, Inc.Common Stock | 2026-10-15 | S sold | -2,853 | $73.8894 | 35,918 | Form 4 |
| ORKA · Oruka Therapeutics, Inc.Common Stock | 2026-10-15 | S sold | -1,847 | $74.6924 | 34,071 | Form 4 |
| ORKA · Oruka Therapeutics, Inc.Common Stock | 2026-10-15 | S sold | -1,400 | $75.4834 | 32,671 | Form 4 |
| ORKA · Oruka Therapeutics, Inc.Common Stock | 2026-10-15 | S sold | -700 | $76.6652 | 31,971 | Form 4 |
| ORKA · Oruka Therapeutics, Inc.Common Stock | 2026-10-15 | S sold | -200 | $77.71 | 31,771 | Form 4 |
| ORKA · Oruka Therapeutics, Inc.Employee Stock Option (right to buy), derivative | 2026-10-15 | M exercised | -3,500 | $0 | 190,063 | Form 4 |
| ORKA · Oruka Therapeutics, Inc.Employee Warrant (right to buy), derivative | 2026-10-15 | M exercised | -3,500 | $0 | 161,492 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0000907654-26-000118 | Oruka Therapeutics, Inc. | 2026-11-16 | ||
| Form 4 0000907654-26-000108 | Oruka Therapeutics, Inc. | 2026-10-15 |